Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 84.64% | 102.83% | -52.75% | -53.53% | -16.46% |
| Total Depreciation and Amortization | 7.53% | 18.13% | 11.53% | 9.71% | 45.95% |
| Total Amortization of Deferred Charges | -44.63% | -39.19% | 3.24% | 1.46% | -14.66% |
| Total Other Non-Cash Items | 7.32% | 17.90% | 170.82% | 169.66% | 170.47% |
| Change in Net Operating Assets | -2,739.40% | -3,018.91% | 7,711.57% | 7,588.86% | -111.05% |
| Cash from Operations | -14.08% | -5.62% | -23.98% | -25.22% | 41.04% |
| Capital Expenditure | -32.99% | -46.16% | -103.31% | -100.00% | 24.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.57% | 55.51% | -465.45% | -454.17% | -92.49% |
| Cash from Investing | -12.24% | -23.27% | -111.56% | -108.09% | -273.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.06% | -24.06% | 25.85% | 25.85% | -78.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.88% | 64.88% | -4,124.85% | -4,124.85% | -10,219.59% |
| Cash from Financing | 64.83% | 61.36% | -34,722.40% | -34,129.92% | -20.70% |
| Foreign Exchange rate Adjustments | -4.48% | -14.75% | 72.02% | 72.43% | -111.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.53% | 91.72% | -40.91% | -41.87% | 73.78% |